Proteasomal degradation of tau protein

被引:278
作者
David, DC
Layfield, R
Serpell, L
Narain, Y
Goedert, M
Spillantini, MG
机构
[1] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge, England
[2] Univ Cambridge, Dept Neurol, Cambridge, England
[3] Cambridge Inst Med Res, Struct Med Unit, Cambridge, England
[4] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
关键词
Alzheimer's disease; paired helical filament; proteasome; tau; ubiquitin;
D O I
10.1046/j.1471-4159.2002.01137.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Filamentous inclusions composed of the microtubule-associated protein tau are a defining characteristic of a large number of neurodegenerative diseases. Here we show that tau degradation in stably transfected and non-transfected SH-SY5Y cells is blocked by the irreversible proteasome inhibitor lactacystin. Further, we find that in vitro , natively unfolded tau can be directly processed by the 20S proteasome without a requirement for ubiquitylation, and that a highly reproducible pattern of degradation intermediates is readily detectable during this process. Analysis of these intermediates shows that 20S proteasomal processing of tau is bi-directional, proceeding from both N- and C-termini, and that populations of relatively stable intermediates arise probably because of less efficient digestion of the C-terminal repeat region. Our results are consistent with an in vivo role for the proteasome in tau degradation and support the existence of ubiquitin-independent pathways for the proteasomal degradation of unfolded proteins.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 56 条
[1]
Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum [J].
Akopian, TN ;
Kisselev, AF ;
Goldberg, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1791-1798
[2]
ABNORMAL PHOSPHORYLATION OF TAU-PRECEDES UBIQUITINATION IN NEUROFIBRILLARY PATHOLOGY OF ALZHEIMER-DISEASE [J].
BANCHER, C ;
GRUNDKEIQBAL, I ;
IQBAL, K ;
FRIED, VA ;
SMITH, HT ;
WISNIEWSKI, HM .
BRAIN RESEARCH, 1991, 539 (01) :11-18
[3]
The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes [J].
Benaroudj, N ;
Tarcsa, E ;
Cascio, P ;
Goldberg, AL .
BIOCHIMIE, 2001, 83 (3-4) :311-318
[4]
Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[5]
Subcellular localization of proteasomes and their regulatory complexes in mammalian cells [J].
Brooks, P ;
Fuertes, G ;
Murray, RZ ;
Bose, S ;
Knecht, E ;
Rechsteiner, MC ;
Hendil, KB ;
Tanaka, K ;
Dyson, J ;
Rivett, AJ .
BIOCHEMICAL JOURNAL, 2000, 346 :155-161
[6]
Canu N, 1998, J NEUROSCI, V18, P7061
[7]
The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology [J].
Carmel, G ;
Mager, EM ;
Binder, LI ;
Kuret, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) :32789-32795
[8]
Structure and functions of the 20S and 26S proteasomes [J].
Coux, O ;
Tanaka, K ;
Goldberg, AL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :801-847
[9]
Degradation of oxidized proteins by the 20S proteasome [J].
Davies, KJA .
BIOCHIMIE, 2001, 83 (3-4) :301-310
[10]
Dick LR, 1997, J BIOL CHEM, V272, P182